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BEYOND THE DALKON SHIELD: PROVING 
CAUSATION AGAINST IUD 
MANUFACTURERS FOR PID RELATED 
INJURY 
Intrauterine devices (IUDs)! have been linked to a wide va-
riety of injuries to women, ranging from severe cramping, to 
spontaneous abortion, to sterility, to death. This Comment will 
focus on the problem of proving that scarring of the fallopian 
tubes, resulting in sterility or partial sterility, is causally linked 
to use of the IUD, and therefore, a provable element in a plain-
tiff's cause of action against a manufacturer for such injuries. 
In spite of sketchy guidance from case law as to what will 
constitute a winning causation argument, a number of medical 
findings can establish that, more likely than not, plaintiff's IUD 
was a cause in fact of her injury: (1) medical studies showing a 
greatly increased risk of pelvic inflammatory disease for women 
who use IUDs, (2) testimony as to the pattern of development of 
the infection, (3) the condition of the device itself when it was 
removed from plaintiff's uterus, (4) the type of bacteria that 
caused the infection, and (5) the wicking action of the device's 
string. 
I. HISTORY OF THE IUD 
The theory behind the IUD is an ancient one. Arabian and 
Turkish camel drivers are thought to have placed pebbles in the 
uteri of their animals to prevent pregnancy.-on long journeys. I 
1. IUDs are small plastic devices of various shapes and sizes. The IUD is inserted 
into the uterus by a doctor or nurse practitioner to prevent pregnancy. 
Exactly how an IUD prevents pregnancy is unknown, but the following mechanisms 
have been proposed: 
(1) The IUD prevents the egg which has been fertilized in the fallopian tube from 
attaching to the uterine wall. The IUD probably accomplishes this by irritating the lin-
ing of the uterus by rubbing against the uterine walls. 
(2) The IUD may cause the egg to move more quickly through the fallopian tube 80 
there is less time for fertilization to occur. 
(3) The inflamed or irritated condition caused by the device creates an increased 
amount of white blood cells which may ingest, or prove toxic to sperm. 
THE BOSTON WOMEN'S HEALTH COLLECTIVE, OUR BODIES, OURSELVES 196 (2d ed. 1979) 
[hereinafter cited as OUR BODIES, OURSELVES]. 
2. Schmidt, IUDs, Inflammation, and Infection: Assessment after Two Decades of 
639 
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The Hippocratic oath decrying the use of a pessary to cause 
abortion, suggests that such devices were used to affect womens' 
reproductive systems even then.3 Diamond studded IUDs are re-
ported as early as the late 1800'S.4 
Throughout their long history, IUDs have been surrounded 
by controversy. Periods of popularity were followed by periods 
of rejection. In 1936 the Japanese government prohibited their 
use completely. & In 1980 there were an estimated 6 million IUDs 
in use throughout the world.6 
In 1909 a precursor to the modern IUD was made from silk-
worm gut. By the 1930's this model had developed into a silk-
worm gut ring held in shape by a wire of silver and copper.' By 
the late 1930's and early 40's the device was associated with such 
a high rate of infection and complications that it was over-
whelmingly condemned by the medical communityi' even though 
it reportedly had a respectable failure rate of only 2.5 per 100 
women per year.9 
Independent articles published in 1959, one by an Israeli re-
searcher and one by a Japanese doctor, both reported the IUD 
to be safe and effective. The Israeli researcher went so far as to 
call the device "absolutely harmless."lo These reports spurred a 
flurry of new research and experimentation in the United States 
in the early 1960's and led to' the development of several new 
models of IUDs.l1 It was later said that "unfortunately [these] 
advocates were careless in their reading, for nothing new or rev-
olutionary had been added to the already existent knowledge."n 
IUD Use, 13 HUM. PATHOLOGY, Oct. 1982, at 878 [hereinafter cited as Schmidt, IUDs 
Assessment]. 
3.Id. 
4.Id. 
5.Id. 
6. HATCHER, STEWART, STEWART, GUEST, SCHWARTZ, & JONES, CONTRACEPTIVE TECH-
NOLOGY 1980-81 at 53 (rev. 10th ed. 1980). [hereinafter cited as CONTRACEPTIVE 
TECHNOLOGY]. 
7. Id. at 52. 
8. G. COREA, THE HIDDEN MALPRACTICE 168 (1977) [hereinafter cited as 
MALPRACTICE]. 
9. CONTRACEPTIVE TECHNOLOGY, supra note 6, at 52. 
10. MALPRACTICE, supra note 8, at 170. 
11. CONTRACEPTIVE TECHNOLOGY, supra note 6, at 53. 
12. MALPRACTICE, supra note 8, at 170. 
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Other evidence points to increased interest in IUDs being 
spurred not by the Israeli and Japanese papers, but by a percep-
tion on the part of family planning and population control ex-
perts that underprivileged populations needed low motivation 
birth control. 13 Birth control programs were considered to be 
cost effective weapons in the war on "newly discovered" poverty 
in America.a In one ghetto clinic in New York City, 55% of the 
women were given the Majzlin Spring because it had been devel-
oped by the director and he was researching a new model. The 
FDA later recalled that model as being associated with an undue 
number of serious complications. III 
Another factor in the surge of renewed interest was the de-
velopment of chemically inert plastics. Ie Such plastics are com-
posed of relatively pure substances and can be straightened for 
insertion; once inside the uterus, they will return to their origi-
nally molded shape. Inert plastics may have made it easier to 
insert and remove IUDs because they don't necessitate dilation 
of the cervix, but the devices weren't necessarily any safer than 
the earlier models. In some cases the inert plastic devices dis-
integrated in utero, requiring a D & C to extract the pieces that 
didn't pass out in fragments. 17 
It was also in the late 1960's and early 70's that the dangers 
of the birth control pill were being widely publicized.18 Women 
who were accustomed to the pill's convenience but alarmed by 
its dangers were more willing to try a new product. 
By 1975 there were an estimated 15 million IUDs in use 
around the world. Around that time, the same problems encoun-
tered in the 1930's and 40's began to emerge. Ie The Dalkon 
Shield in particular caused the most damage and became one of 
the most widely litigated products in pharmaceutical history.so 
The Shield, manufactured by the A.H. Robins Company had a 
13. [d. at 169. 
14. Sharpe, The Birth Controllers, in SEIZING OUR BODIES 68 (C. Dreifus ed. 1978) 
15. MALPRACTICE, supra note 8, at 157. 
16. Schmidt, IUDs Assessment, supra note 2, at 878. 
17. MALPRACTICE, supra note 8, at 169. 
18. Dowie & Johnston, A Case of Corporate Malpractice and the Dalkon Shield, in 
SEIZING OUR BODIES, 89 (C. Dreifus ed. 1978) [hereinafter SEIZING OUR BODIES). 
19. MALPRACTICE, supra note 8, at 171. 
20. SEIZING OUR BODIES, supra note 18, at 88. 
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design and composition that set it apart from other IUDs and 
caused more medical complications than any of the others. The 
unique physical characteristics of the Shield and the possibility 
of fraud on the part of its inventor and manufacturer, make 
proof of liability much clearer for it than for other types of 
IUDs. For that reason the Dalkon Shield will be discussed only 
in a footnote and this Comment will concentrate on IUDs in 
general, and not on anyone in particular. 21 
21. The Dalkon Shield is an IUD which was developed by an independent inventor 
and later sold to the A.H. Robins Company in the early 1970's. The Shield differs from 
most other IUDs in that it has small protrusions intended to reduce the chance of expul-
sion. The Shield also differs from other IUDs because of its polyfilamented (more than 
one strand) string. Other IUDs are monofilamented and have only one strand. This 
string is connected to the IUD and passes through the cervix into the vagina. It has been 
established that the polyfilamented string creates a "wicking action," drawing bacteria 
from the vagina through the cervix and into the relatively sterile uterus. Some doctors 
feel that the presence of any foreign body in the uterus connected by any kind of thread 
reaching through the cervical canal into the vagina makes it more likely that certain 
infections will be drawn into the upper genital tract where they can cause serious dis-
ease. It is also believed that IUDs tend to exacerbate any infection already present in the 
uterus. Guilleband, The Safety of IUDs, 10 STUD. FAM. PUN. 174,175 (1979) [hereinafter 
cited as Safety of IUDs]. 
Before the Shield went on the market, only one study was done by its inventor to 
determine the pregnancy rates to be used in future advertising of the product. His re-
sults were published in the American Journal of Obstetrics and Gynecology in February 
1970 and showed an impressive 1.1 % pregnancy rate. The article received widespread 
press attention, since it was at about this time that the dangerous side effects of the 
birth control pill were being discovered and publicized. It was later uncovered that the 
inventor had told many of the women in his study to use spermicidal foam during part of 
their cycles, a fact which makes his pregnancy rate questionable at best. It also turned 
out that less than half of the women in the study used the device for a full year. SEIZING 
OUR BODIES, supra note 18, at 91. Later, when the Robins Company was negotiating to 
buy the rights to the Shield, the pregnancy rate was discovered to be 6%. Advertise-
ments in medical journals beginning in December 1970, however, contained the original 
1.1 % rate. Id. at 90. Robins did additional testing and claimed that the Shield permitted 
only a 3% pregnancy rate, which it duly reported in its ads. Id. Private studies per-
formed in Boston and Sacramento at the same time and which were sent to Robins, 
produced pregnancy figures of 10.1 % and 5.6% respectively. Id. at 97. These reports 
were not investigated further by Robins, nor were its advertising figures changed. Id. 
In 1971, a physician working in another division of the Robins Company discovered 
that the multifilamented string displayed wicking qualities, which she predicted might 
lead to serious infection. Id. at 96. When she reported her findings to the IUD division of 
Robins, she was told that her findings would be investigated further by the company's 
microbiologist. Id. at 97. No further action was taken, and when outside doctors inquired 
about whether the infections they were seeing could have been caused by this wicking 
action, Robins replied that as far as it knew, the problem did not exist. Id. at 96. 
Between 1970 and 1973, Robins received numerous complaints from doctors across 
the country that its product was causing PID and other problems. See Note, The In-
trauterine Device: a Criticism of Government Complaisance and an Analysis of Manu-
facturer and Physician Liability, 24 CLEv. ST. L. REV. 247, 274 (1975) [hereinafter cited 
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II. PELVIC INFLAMMATORY DISEASE: THE MEDICAL VIEW 
Damage to the fallopian tubes may be caused by pelvic in-
flammatory disease (PID) or as it is otherwise known, salpingi-
tis, which is an infection of the fallopian tubes and ovaries 
caused by one or more of a number of different bacteria. These 
infections cause the tubes to abscess or scar, which in many 
cases cause them to become blocked so that the unfertilized egg 
cannot travel through the tube to the uterus where fertilization 
takes place, thus rendering the woman totally or partially infer-
tile. The most reliable way to determine whether the tubes have 
been completely blocked is a painful surgical procedure called a 
hysterosalpingogram, where a dye is forced through the tubes 
and then x-rayed to determine the configuration of the tube. 22 
There are an estimated half million cases of first time PID 
each year in the United States.2S If PID is diagnosed early 
enough, it can be controlled with high doses of antibiotics, and 
the damage will be limited to partial or no tube scarring. If the 
PID has sufficiently progressed before it is diagnosed, however, 
it may cause sterility. In some cases it may be necessary to re-
move one or both tubes and the ovaries, or peform a total hys-
as Note, Criticism]. In addition to burying findings that it did not want anyone to know 
about, and failing to advertise accurate pregnancy rates, there is evidence that Robbins 
made certain misstatements in brochures that went to doctors and patients. These mis-
statements include "but we do know it's harmless," and "the Food and Drug Administra-
tion is kept informed about the progress with these devices." These same brochures vir-
tually ignored the serious side effects and complications of IUDs. See generally Hearings 
on Intrauterine Contraception Devices Before a Subcomm. of the House Comm. on Gov-
ernment Operations, 93d Cong., 1st Sess. 80-108 (1973). 
When the dangerous effects of the Shield were widely publicized in 1973 as a result 
of Congressional hearings, id., the Robins Company sent a letter to all doctors advising 
them of the possible dangers associated with the device, and for the first time included 
complete warnings in their package inserts. SEIZING OUR BODIES, supra note 18, at 99. 
Robins also informed doctors at that time that if their patients currently using the de-
vice were not having any problems, then it was safe for them to leave the device in place 
and rely on it for contraception. (From interview with a Dalkon Shield plaintiff, San 
Francisco, California (March 1982).) No general recall of the device has ever been made. 
22. Barbot, Parent, & Dubuisson, Contact Hysteroscopy: Another Method of Endo-
scopic Examination of the Uterine Cavity, 136 AM. J. OBSTETRICS & GYNECOLOGY 721, 
723 (1980). Even though no cutting is involved, a hysterosalpingogram is considered to 
be a surgical procedure since it is performed in an operating room under general anesthe-
sia. See also WHITEHOUSE, GYNECOLOGICAL RADIOLOGY, 20, 73-86, 151-52 (1981); BENSON, 
CURRENT GYNECOLOGIC TREATMENT, 929-30 (1980). 
23. Digest-IUD Users Have Higher Risk of Contracting PID, Studies Find; Pill 
May Have Protective Effect, 12 FAM. PLAN. PERSP. 260, 260 (1980) [hereinafter cited as 
Digest IUD]. 
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terectomy in order to prevent the infection from spreading.24 
One of the major problems of treating PID in order to pre-
vent major damage is that it is often difficult to diagnose. Its 
symptoms, such as nausea, fever, and severe cramping, are vague 
and easily attributable to a number of conditions. Doctors often 
respond to those symptoms by testing a complaining patient for 
gonorrhea and/or pregnancy, and it may be several weeks before 
a test for PID is made.lUI Many doctors feel that the only way to 
tell definitely if a patient has PID is to perform a laparoscopy.26 
Physicians are understandably hesitant to perform surgery every 
time a patient complains of nausea and cramps, and as a result, 
injuries from PID advance and worsen because the infection is 
not caught in its early stages. 
"It appears that the IUD itself makes the bearer more sus-
ceptible to PID, other factorsnotwithstanding."27 Incidence of 
PID correlates more closely with the use of IUDs than with the 
use of any other method of birth control. PID is an increasingly 
prevalent health problem, and "the increasing use of the IUD as 
a means of fertility control almost certainly also contributes to 
the problem. "2S In the past few years results from numerous 
medical studies have indicated a greatly increased incidence of 
PID in women who have IUD's. 
"Nevertheless, studies are remarkably consistent 
in estimating the increased risk of PID in IUD 
users as between roughly 3 and 9 fold overall; the 
24. OUR BODIES, OURSELVES, supra note I, at 175. 
25. This presents a classic case of the medical profession refusing to believe that 
women are medically informed and that they know what is going on with their bodies. 
One woman interviewed for this paper, supra note 21, said that she went to the emer-
gency room with severe cramps, dizziness and nausea, that she told the doctor she had 
an IUD and that he ought to remove it. He kept her waiting for a number of hours and 
tried to convince her that she was either pregnant or had gonorrhea, even though she 
insisted that both were physically and medically impossible as she had not had inter-
course for four months. 
26. Golden, Better Diagnosis Could Aid Against Pelvic Inflammatory Disease, 243 
J.A.M.A., June 27, 1980, at 2471, 2472. A laparoscopy is a procedure whereby an instru-
ment called a laporoscope is inserted through the abdomen so that the doctor can ob-
serve the tubes and uterus directly. A dye is introduced through the uterus to help in the 
viewing. 
27. Schmidt, IUDs Assessment, supra note 2, at 878. 
28. Eschenback & Holmes, Acute Pelvic Inflammatory Disease: Current Concepts 
of Pathogenesis, Etiology, and Management, 18 CLINICAL OB/GVN, March 1975, at 35. 
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lower figure for older parous [those who have al-
ready had a child] women, and the higher figure 
to younger, nulliparous [those who have not yet 
had a child] women. . . . The consistency of these 
reports strongly suggests that the association is 
causal .... "29 
645 
One often-cited study whose authors claim to represent the 
first large cohort study30 to examine the relationship between 
PID and IUDs, found that hospital admission rates for PID were 
1.5 per 1000 women per year among those women currently us-
ing an IUD and 0.14 per 1000 women per year among those us-
ing other forms of birth control. That is, PID was over 10 times 
more common in women with IUDs than in women who used 
some other form of birth control. Another study found that 
women who had used an IUD for 5 years had a 12.9 times 
.greater risk of contracting PID than women who did not use the 
device, and those who used an IUD for less than 5 years had a 
5.7 times greater risk than non users.31 
Some studies have indicated that women who become sexu-
ally active at an earlier age, and women with multiple partners, 
have a higher risk of PID.32 This is generally thought to be a 
result of increased exposure of these women to harmful bacteria 
in general, and more specifically to increased exposure to gonor-
rhea. Defense attorneys have relied on these facts in an attempt 
to establish that plaintiff's PID was in fact caused by her "im-
moral" sex life, and not by the defendant's IUD.33 Previous gon-
orrhea is also statistically correlated to subsequent PID and to 
the recurrence of PID. Gonorrhea has been found to cause fallo-
pian tube damage which often doesn't manifest itself until years 
later when the women experience difficulty in becoming preg-
nant. It is hypothesized that unrecognized tubal damage as a re-
sult of gonorrhea might have the effect of impairing the bacterial 
balance in the tube, predisposing the patient to the higher rate 
29. Safety of IUDs, supra note 21, at 175. 
30. Vessey, Yeates, Flavel, & McPherson, Pelvic Infiammatory Disease and the In-
trauterine Device: Findings in a Large Cohort Study, 282 BRIT. MED. J., March 14, 1981, 
at 885. A cohort study is one which follows a group of experiment subjects over a period 
of years. 
31. Digest IUD, supra note 23, at 207. 
32. Id. at 206. 
33. Interview with Dennis Conklin, piantiif's personal injury attorney, San Fran-
cisco, California (April 1982). 
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of PID.34 A study that compared a group of women with gonoc-
cocal PID, to a group suffering from nongonoccocal PID, how-
ever, established no significant difference between the groups in 
frequency of intercourse per week or in number of sex partners 
in the six months preceding the study.311 More importantly, the 
researchers found that IUD users were four times more likely to 
develop PID than non-users.38 
Several theories have developed to explain how the IUD can 
cause a pelvic infection or how it can severely aggravate an ex-
isting pelvic infection in its early stages. One commonly held 
theory is that the IUD prevents conception by causing a slight 
inflammation of the uterus, thereby creating a hostile uterine 
environment which prevents the fertilized egg from implanting 
and developing.3" The inflammation caused by the IUD, it is rea-
soned, renders the uterus more susceptible to a full-blown 
infection. 
PID can be caused by a doctor's negligence in inserting the 
device despite medical contraindications. If a doctor decides to 
insert an IUD in a woman who has had previous pelvic infec-
tions or ectopic pregnancies,s8 s/he is seriously increasing the pa-
tient's chances of contracting PID again89 because IUDs aggra-
vate already infected or inflammed tissue. 
34. Eschenback, Harnisch, Holmes, Pathogenesis of Acute Pelvic Inflammatory 
Disease: Role of Contraception and Other Risk Factors, AM. J. OBSTETRICS & GYNECOL-
OGY, August IS, 1977, at 838, 847 [hereinafter cited as Pathogenesisj. 
Of 253 women studied, "some form of salpingitis was found in 54 % of the IUD 
group and in only 6% of the control group ... As the IUD and control group were 
comparable in all investigated parameters, the inflammatory reaction must be caused by 
the method of contraception." Beerthruzen, Van Wyck, Eskes, Vermeulen, & Vooijs, 
IUD and Salpingitis: A Prospective Study of Pathomorphological Changes in the Ovi-
ducts of IUD Users, 13 EUR. J. OBSTETRICS, GYNECOLOGY, & REPRODUCTIVE BIO., Febru-
ary 13, 1982, at 31, 31. 
35. See Pathogenesis, supra note 34, at 840. 
36. Pathogensis, supra note 35, at 847. 
37. When the sperm and the egg meet in the fallopian tube, they form a zygote 
(fertilized egg) which travels into the uterus and becomes implanted on the uterine wall. 
The zygote divides and develops into a fetus. 
38. An ectopic pregnancy is one in which the fertilized egg implants itself, not in the 
wall of the uterus, but most often in the fallopian tube, or much more rarely in the 
abdominal cavity, the ovary, or the cervix. OUR BODIES, OURSELVES, supra note I, at 324. 
39. Interview with Jack Futeron, M.D., OBGYN, San Francisco, California (April 
1982). 
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A second theory linking the IUD with PID is that the infec-
tious organisms enter the uterus when the IUD is inserted. This 
may occur if the IUD is not properly sterilized before insertion. 
It can also occur if care is not taken to ensure that organisms 
from the vagina aren't pushed through the cervical canal along 
with the IUD.40 
PID has also been associated with the wicking action of the 
string that is attached to the device and passes through the cer-
vix into the vagina.41 Other theories, however, link the presence 
of any foreign body in the uterus connected by any kind of 
thread reaching through the cervical canal with increased like-
lihood of infections being drawn into the upper genital tract. It 
is also suggested that IUDs tend to cause any pre-existing infec-
tion in the uterus to become more serious, and that stringless 
IUDs do not have infection rates any lower than those with 
strings, monofilamented or otherwise.42 
It is possible to determine that PID is IUD related by exam-
ining the manner in which the infection spread.48 Classic PID in 
the absence of a device is bilateral-both tubes are infected. 
PID caused by an IUD is usually unilateral, with only one side 
infected. When it is apparent that the infection is only present 
on one side, or that the infection started on one side and then 
spread, it is clear that the infection was IUD related.44 This usu-
ally happens when the device becomes embedded in one side of 
the uterus and then aggravates an infection.411 
The type of bacteria which created the infection should also 
be examined. Actinomyces Israelii is an organism that can cause 
PID and is not sexually transmitted.46 "It is our belief that the 
recognition of actinomyces in the vaginal smear is always associ-
40. Information handout written by the Women's Needs Center, San Francisco, Cal-
ifornia (1981). 
41. See supra note 21. 
42. Safety of IUDs, supra note 21, at 175. 
43. Interview with Jack Futeron, M.D., supra note 39; See Schmidt, IUDs Assess-
ment, supra note 2, at 879. 
44. [d. 
45. Interview with Jack Futeron, M.D., supra note 39. 
46. See Brenner & Gehring, Pelvic Actinomycosis in the Presence of Endocervical 
Contraceptive Devices, 29 AM J. OBSTETRICS & GYNECOLOGY, January 1967, at 71. 
9
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ated with a foreign body, most commonly an IUD."47 New re-
search linking uterine actinomyces to IUDs indicates that there 
is no safe IUD and urges the nearly 3 million American women 
using intrauterine devices to use another form of 
contraception.48 
Actinomyces-linked PID "is uncommon unless associated 
with IUDs and is clearly different from the more usual, bilateral 
PID."49 Such PID is almost always unilateral, involves massively 
destructive tubo-ovarian abscesses, and causes sterility in a large 
number of cases.IIO Very recent research into this variation of 
PID suggests that its incidence has nothing to do with the pro-
miscuity of the victim, but rather with the length of time she 
had an IUD in her uterus, as biodegradation and biotransforma-
tion of the surface of the device over time is an essential patho-
genic component. III Actinomyces is such a strong indicator of a 
disposition towards infection, that doctors recommend immedi-
ate removal of an IUD even in asymptomatic women who show 
actinomyces on their pap smears. 52 
Another theory linking PID and IUDs is that use of the de-
vice reduces the efficiency of local natural barriers that protect 
against the spread of bacteria into the upper genital tract.1I3 Still 
another theory is that the device promotes vaginal polymicrobial 
47. Gupta & Woodruf, Actinomyces in Vaginal Smears, 247 J.A.M.A., Feb. 1982, at 
1175 (emphasis added). 
48. Gupta, unpublished research as reported in San Francisco Examiner, March 4, 
1982, at A16, col. l. 
Recent research shows that actinomyces infection can spread throughout the body 
causing serious problems. In a case study, a woman was found to have a cranial abscess 
containing actinomyces four years after she had undergone a complete hysterectomy to 
contain her PIO. At the time of the hysterectomy, her doctor mistakenly assumed that 
the removal of the infected organs would end the infection and so did not prescribe any 
antibiotics. de la Monte, Gupta, & White, Systemic Actinomyes Infection: A Potential 
Complication of Intrauterine Contraceptive Devices, 248 J.A.M.A., Oct. 1982, at 1876-
77. 
49. Schmidt, IUDs Assessment, supra note 2, at 879 citing Schmidt, Bedrassian, & 
Ali, Actinomycosis and Intra-Uterine Contraceptive Devices: The Clinicopathologic En-
tity. 2 DIAGN. GYNECOLOGY & OBSTETRICS 165-177 (1980). 
50.ld. 
5l. Schmidt, IUDs Assessment, supra note 2, at 879. 
52. Burkman, Schlesselman, McCaffery, Gupta & Spence, The Relationship of Gen-
ital Tract Actinomyces and the Development of Pelvic Inflammatory Disease, 143 AM. 
J. OBSTETRICS & GYNECOLOGY, July 1, 1982, at 585, 588. 
53. Eschenback & Holmes, supra note 28, at 40. 
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overgrowth, (growth of more than the usual amount of bacteria 
in the vagina) that later causes upper genito-urinary tract 
infections.1I4 
III. PROCEDURAL PROBLEMS OF THE STATUTE OF LIMITATIONS 
The initial problem confronted by a plaintiff attempting to 
sue for injuries caused by an IUD is the bar posed by the statute 
of limitations. 
California, for example, has a one year statute of limitations 
for injuries or death resulting from a wrongful act or failure to 
act. lill The statute implicitly establishes that the limitations pe-
riod begins to run "after the cause of action shall have ac-
crued."os Generally, a cause of action accrues when the wrongful 
act is committed and the plaintiff has sustained injuries for 
which relief could be granted.07 
This rule is extremely harsh when applied to IUD related 
injuries because in many cases the full extent of the damage or 
the fact that the injuries may be causally connected to the IUD, 
is not discovered until more than one year after the wrongful act 
has occurred.08 To reduce the harshness of the rule on plaintiffs, 
the California courts have established a number of exceptions to 
the rule which have the effect of tolling the statute of 
limitations.09 
54. See Golden, supra note 26, at 2472. 
55. CAL. CIV. PROC. CODE § 340(3) (Deering 1972). This section reads "an action for 
. . . injury to or for the death of one caused by the wrongful act or neglect of another 
" 
56. CAL. CIY. PROC. CODE § 312 (Deering 1972). 
57. United States Liab. Ins. Co. v. Haidinger-Hayes, Inc., 1 Cal. 3d 586, 596, 463 
P.2d 770, 776, 83 Cal. Rptr. 418, 424 (1970); See. e.g .• 2 WITKIN, CALIFORNIA PROCEDURE § 
263 (2d ed. 1970) [hereinafter cited as WITKIN. PROCEDURE). In California. under a strict 
accrual theory, two corollary theories exist which reduce the ability of an IUD plaintiff to 
receive redress for her injuries. 
The first theory is that section 340 begins to run even though the plaintiff i8 igno-
rant of the fact that she has a cause of action. See Rubino v. Utah Canning Co .• 123 Cal. 
App. 2d 18. 27. 266 P.2d 163.168 (1954). c.{. Warrington v. Charles Pfizer & Co .• 274 Cal. 
App. 2d 564. 80 Cal. Rptr. 130 (1969). 
Under the second theory. section 340 will begin to run even if the plaintiff did not 
sustain any significant injuries at the time. See Sanburgh v. MacQuarrie. 112 Cal. App. 
2d 771, 773, 247 P.2d 133, 135 (1952), See generally WITKIN, PROCEDURE. supra at §§ 
264-65. 
58. See supra note 48. 
59. See WITKIN, PROCEDURE, supra note 57, at § 266. 
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The exceptions to the rule are most easily illustrated in the 
case of Nelson v. A.H. Robins CO.,60 where the Federal District 
Court of Northern California applied the California statute of 
limitations.61 In Nelson, a woman who was rendered infertile, al-
legedly from her IUD, was held not to be barred from suing the 
manufacturer, despite the fact that the one year statute of limi-
tations was long past. Plaintiff's IUD was inserted in February 
of 1971.62 In July, 1971 she experienced fainting and cramps. 
Her doctor diagnosed PID and removed her IUD immediately.63 
He told her that the IUD was infected and prescribed antibiot-
ics. She had no further problems until January 1973 when she 
tried unsuccessfully for a year to become pregnant.64 The doctor 
informed her that her tubes were scarred from PID.6C1 He oper-
ated, and told her that he had been able to clear them. In 1977 
plaintiff had still not become pregnant. The doctor performed 
tests and pronounced that her tubes were totally blocked and 
that she was sterile.66 Plaintiff then brought suit against the 
manufacturer of the device-over six years after the apparent 
date of the onset of the injury.6? 
The Nelson court outlined four exceptions which may toll 
the one year statute of limitations: 
(1) Where there is no single wrongful act, but 
rather a period of exposure which results in a con-
tinuing injury, the statute is tolled until the time 
plaintiff knew or should have known that she was 
suffering from a disease that was likely to cause 
her injury;88 
(2) When plaintiff's injury involves pathologi-
cal effects occuring without perceptible trauma;89 
(3) When plaintiff's failure to bring a cause of 
60. 515 F. Supp. 623 (N.D. Cal. 1981). 
61. See 28 U.S.C. § 1332(a) (1976). Erie R. Co. v. Tompkins, 304 U.S. 64 (1938), 
held that a federal district court, while sitting in diversity jurisdiction, must apply the 
substantive law of the state of its situs. 
62. 515 F. Supp. at 624. 
63.Id. 
64.Id. 
65.Id. 
66.Id. 
67.Id. 
68. Id. at 625 (citing Velasquez v. Fibreboard Paper Prod., 97 Cal. App. 3d 881, 887-
89, 159 Cal. Rptr. 113, 117-18 (1979». 
69. 515 F. Supp. at 625. 
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action is a result of defendant's fraudulent con-
cealment of facts relating to discovery of a poten-
tial cause of action;70 
(4) When a person, although aware that an 
injury has occurred, has not yet discovered that 
her/his injury was caused by defendant's conduct 
or a defective product.71 
651 
It is this final exception which was at issue in Nelson. The 
Nelson court framed the issue as such-when did the plaintiff 
possess "facts that identified a conclusive relationship between 
her injuries and the defendant's alleged defective product."72 
In determining the moment at which the plaintiff suffi-
ciently discovered the source of her injury, the court scrutinized 
the information that plaintiff received from her doctor when her 
IUD was removed in July of 1971.73 When the IUD was removed 
the plaintiff's doctor informed her that "it [the IUD] was obvi-
ously infected and causing her problems."74 
The court found that this statement was insufficient to ap-
prise the plaintiff of the source of her injury, and held that as a 
matter of law, 
[T]he information which the plaintiff must pos-
sess with respect to the diagnosis relating her in-
juries to a particular product is meant to be . . . 
an "informed diagnosis" roughly parallel to "in-
formed consent" in medical malpractice or bat-
tery actions. The physician's diagnosis must. be 
such ... that the patient knew or should have 
known that the defendant's allegedly defective 
product caused her injuries. 7~ 
70. 515 F. Supp. at 625. See e.g., Warrington v. Charles Pfizer Co., 274 Cal. App. 2d 
564, 569-70, 80 Cal. Rptr. 130 at 133-34 (1969). This exception includes some "other 
valid excuse" which plaintiff may be able to produce. [d. 
71. 515 F. Supp. at 626; In re Dalkon Shield IUD Products Liability Litigation: Sid-
ney-Vinstein v. A.H. Robins Co., 503 F. Supp. 194, 197 (N.D. Cal. 1980); Warrington v. 
Charles Pfizer Co., 274 Cal. App. 2d at 572-73, 80 Cal. Rptr. at 135 (statute of limitations 
was tolled because of defendant's false representations to the public and to the medical 
profession regarding the safety of its products). 
72. 515 F. Supp. at 626 (emphasis added). It must be noted that the defendant's 
motion for summary judgment in Nelson was made after a single deposition had been 
taken. [d. 
73. Supra note 63 and accompanying text. 
74. 515 F. Supp. at 624. 
75. 515 F. Supp. at 626 (emphasis added) (citing as to the parallel to informed con-
13
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The Nelson court reasoned that the doctor's statement to 
the plaintiff in July, "raises dual inferences as to its effect on the 
state of mind of the plaintiff's knowledge as to the precise cause 
of her injuries. "76 
The exceptions outlined in Nelson provide the prospective 
IUD plaintiff with several methods of circumventing the Califor-
nia statute of limitations. While the Dalkon Shield cases are rep-
resentative of the "fraudulent concealment" exception," Nelson 
clearly illustrates the "discovery" exception. Neither the "patho-
logical effects" nor the "perceptible trauma" exceptions have 
been at issue with regard to an IUD case. These last two theo-
ries, however, are of far less utility to IUD plaintiffs because of 
the existence of the "discovery" rule which is more flexible and 
therefore adaptable to the varied fact situations involved in IUD 
related PID cases.78 
IV. IUDs AND THE SUBSTANTIVE LAW 
A. Strict Liability 
Actions premised on the theory of strict liability in tort fo-
cus not on the manufacturer's conduct, but on the product itself. 
The policy basis of strict liability in tort is that the manufac-
turer, who can absorb the cost through insurance, or spread the 
cost through a consuming population, is in the best position to 
pay for injuries suffered by victims of a defective product it put 
on the market. Strict liability, it has been argued, is an incentive 
to manufacturers to produce safe products by adequately testing 
them and insuring against defects prior to putting them into 
commerce.78 
sent. Velasquez v. Fibreboard, 97 Cal. App. 3d at 888-89, 159 Cal. Rptr. at 117-118). 
76. 515 F. Supp. at 626. 
77. See In Re Dalkon Shield IUD Products Liability Litigation: Sidney-Vinstein v. 
A.H. Robins Co., supra note 71. See also supra note 21. 
78. Both of these exceptions are much better suited to the situation presented 
where the plaintiff is suffering from injuries received because of long term exposure to 
harmful substances which cause disease that become more severe with time and eventu-
ally incapacitate the plaintiff. See Velasquez v. Fibreboard, 97 Cal. App. 3d 881, 159 Cal. 
Rptr. 113, (continuing wrong theory used). 
79. The testing of drugs is closely regulated by the FDA. Therefore before any drug 
is put on the market, it must conform to that agency's specified amount and kind of 
testing. When the Dalkon Shield first went on the market (around 1969), however, the 
FDA did not require testing of medical devices. Because IUDs were classified as such, 
little testing was done before the device was sold, and the results of that testing were not 
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A manufacturer is strictly liable in tort in California when 
an article it places on the market, knowing that it is to be used 
without inspection for defects, proves to have a defect that 
causes injury to a human being.80 Strict liability in tort was 
adopted by the Second Restatement of Torts to require that 
"[o]ne who sells any product in a defective condition unreasona-
bly dangerous to the user . . . or to his property is subject to 
liability for physical harm thereby caused .... "81 In Cronin v. 
JBE Olsen Corp.82 and later in Barker v. Lull Engineering CO.83 
the California Supreme Court rejected the unreasonably danger-
ous requirement of the Restatement by saying it would not be 
part of the plaintiff's burden of proof to show that the product 
was unreasonably dangerous as well as being defective, as this 
would inject an element of negligence into a strict liability the-
ory and would be unduly burdensome for plaintiff to prove. 
The Barker court went on to define a defectively designed 
product as one (1) that fails to meet ordinary consumer expecta-
tions as to safety in its intended or reasonably forseeable opera-
tion, or, (2) which even if it satisfies ordinary consumer expecta-
tions, the jury finds through hindsight to embody "excessive 
preventable danger" (that is the risk of danger inherent in the 
design outweighs the benefits of such a design.)84 Once the 
plaintiff makes a prima facie showing that the injury was proxi-
mately caused by the product's design, the burden of proof 
shifts to the defendant to show that the product is not defec-
tive.811 Thus a product can be found to have a defective design if 
plaintiff proves it did not meet ordinary consumer expectations 
when used in an intended or reasonably foreseeable manner, or 
if plaintiff proves that the design proximately caused his/her in-
juries and defendant fails to establish that the benefits of the 
design outweigh the risk of danger inherent in that design.88 
reported to any government agency. The incentive reasoning behind strict liability in 
tort applies perfectly to the Dalkon Shield. The Robins Company apparently decided not 
to try to cut down their future losses. 
80. Greenman v. Yuba Power Prod., Inc., 59 Cal. 2d 57, 62, 377 P.2d 897, 900, 27 
Cal. Rptr. 697, 700 (1962). 
81. See RESTATEMENT (SECOND) OF TORTS § 402 A (1965). 
82. 8 Cal. 3d 121, 501 P.2d 1153, 104 Cal. Rptr. 433 (1972). 
83. 20 Cal. 3d 413, 573 P.2d 443, 143 Cal. Rptr. 225 (1978). 
84. Id. at 430, 573 P.2d at 454, 143 Cal. Rptr. at 236. 
85. Id. at 431, 573 P.2d at 455, 143 Cal. Rptr. at 237. 
86. Id. at 432, 573 P.2d at 455, 143 Cal. Rptr. at 237. 
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Applying the first prong of the Barker test87 to the IUD, it 
is reasonable that the average consumer would expect that after 
it is inserted, her IUD would safely prevent her from becoming 
pregnant. IUDs were advertised as being a safe alternative to the 
birth control pill, and particularly good for women who had not 
yet had children.88 The average consumer would certainly not 
expect her effortless birth control to cause sterility, infection, 
hemorrhaging, and birth defects.88 
The second definition of defect in Barker90 involves a bal-
ancing of whether the risk of danger inherent in the design out-
weighs its benefits. Under this test it might be harder to prove 
that an IUD's design was defective. 
If the benefits of the device's design are seen as highly relia-
ble birth control (very low risk of pregnancy) with no user par-
ticipation needed, then to some reasonable people it would have 
an extremely high utility, and its benefits might outweigh its 
dangers. Other reasonable people who might find contraception 
(especially effortless contraception), a low priority, could find 
the device to be of very low utility, and then its dangers might 
outweigh its benefits. 
From a systemic, or epidemiological point of view, it may be 
easier to see how the dangers of IUDs outweigh their benefits. 
When considering an IUD as an effective and effortless method 
of birth control, it may seem best to prescribe them for young 
women who have not had children and who will have multiple 
sex partners. But from a health and safety point of view, IUDs 
are considered best prescribed to older women who have already 
87. [d. at 430, 573 P.2d at 454, 143 Cal. Rptr. at 236. See Note, Criticism, supra 
note 21, at 272, 73. 
88. MALPRACTICE, supra note 8, at 174; SEIZING OUR BODIES, supra note 18, at 95. 
89. The consumer's low expectation of problems associated with the device is rein-
forced by the fact that it must be inserted by a doctor. The consumer's expectations in a 
medical case are very much colored by what her doctor tells her. When the IUD was first 
widely marketed, doctors were told of only a few of its dangerous possibilities even 
though its dangers were known to manufacturers at the time. See Note, Criticism, supra 
note 21, at 273, 288-90. If, as is the case here, the consumer's expectation is very much 
influenced by the doctor, and the doctor has not been fully informed of the dangers, it is 
reasonable to believe that the consumer would have no greater expectation of dangerous 
consequences than the level of danger that was communicated to her by her doctor. 
90. 20 Cal. 3d at 430, 573 P.2d at 454, 143 Cal. Rptr. at 236. 
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had all the children they want, as the risks of infection are lower 
for the latter group because their uteri and cervixes are larger so 
the device is more easily inserted and will not cause as much 
inflammation.91 Also, the results of infection are possibly less 
disasterous for an older woman. Sterility, although traumatic, 
may be less so for a woman who has already had all the children 
she wants than for a woman who has not yet had any children. 
In determining whether IUDs are defective under the sec-
ond prong of the Barker test,92 their relative benefits and dan-
gers can also be compared with hindsight to the dangers of other 
modern forms of birth control. The weighing of the burdens and 
the benefits depends to a large extent on the relative values at-
tached to women's health, safe and easy contraception, and to 
high profits for pharmaceutical companies. A manufacturer may 
contend that this test involves a hindsight analysis, and that the 
courts have never held that manufacturers have a duty to warn 
about dangers of which they themselves had, and could not have 
had, any idea at the time of the injury.93 To require the manu-
facturer to compose a warning of side effects not suggested by 
careful laboratory procedures preceding the distribution of the 
drug would be to require a semantically impossible warning.'" 
However, should a manufacturer attempt to apply this to an 
IUD situation, a court could easily find that manufacturers 
should have been alerted to dangers they themselves had not 
found in pre-market testing, by the results of use of IUDs in 
earlier periods of their history.911 
B. Negligence 
A manufacturer is negligent when it can be shown that it 
had a duty, that it breached the duty, and that the breach of 
duty was a cause-in-fact and proximate cause of plaintiff's 
Injury. 
Negligence based on a breach of the duty to warn is fre-
91. Ziff, The IUD and Pelvic Infection, 24 AM. FAM. PHYSICIAN, Dec. 24, 1981, at 
109, 113. 
92. 20 Cal. 3d at 430, 573 P.2d at 454, 143 Cal. Rptr. at 236. 
93. Christofferson v. Kaiser Found. Hosp., 15 Cal. App. 3d 75, 79, 92 Cal. Rptr 825, 
827 (1971). See also Annot., 53 A.L.R. 3d 292 (1973). 
94. 15 Cal. App. 3d at 80, 92 Cal. Rptr. at 827. 
95. See supra notes 2-54 and accompanying text. 
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quently asserted in cases where an injury has been caused by a 
drug or medical device.98 Courts have held that the manufac-
turer of a drug has a duty to warn the medical profession if it 
knew or should have known, of potential dangers of that drug, 
even if the dangers will injure only a small percentage of the 
users. However, this duty to warn extends only to the doctor. 
The manufacturer has no duty to warn the patients directly.9? 
As with all negligence cases, the burden of alternative conduct 
must be weighed against reduction in risks to be achieved by 
such a warning. It cannot be disputed that the burden of accu-
rate package inserts as a warning to doctors is outweighed by the 
benefit of increased health and fertility derived from such a 
warning. A proper warning to doctors could result in fewer IUDs 
prescribed or at least fewer prescribed to women who run a high 
risk of developing PID. It is apparent that many women would 
have IUDs even if told of the dangers, but it is equally apparent 
that many others would heed the warnings, were they given in a 
timely fashion. 
In IUD cases, as in the case of drugs,98 the doctor is an in-
tervening par.ty between the manufacturer and the ultimate user 
of the product, the patient. The doctor is also a necessary inter-
vening party because it is thought that if the average patient 
were given all of the highly technical medical information neces-
sary to make an informed decision, she would not have the abil-
ity to evaluate fully and understand its import. It is also virtu-
96. One who supplies [a product] directly or through a third person [in 
our case, the doctor] for another to use is subject to liability to 
those whom the supplier should expect to use the [product] 
with the consent of the other. . . for physical harm caused by 
use of the [product] in the manner for which and by a person 
for whose use it is supplied if the supplier: 
(a) knows or has reason to know that the [product] is likely to 
be dangerous for the use for which it is supplied, and 
(b) has no reason to believe that those for whose use the 
[product] is supplied will realize its dangerous condition, and 
(c) fails to exercise reasonable care to inform them of its dan-
gerous condition or the facts which make it likely to be 
dangerous. 
RESTATEMENT (SECOND) OF TORTS § 3SS (1965). 
97. See Love v. Wolf, 226 Cal. App. 2d 378, 394, 38 Cal. Rptr. 183, 193 (1964). See 
McKee v. Moore, 648 P.2d 21 (Okla. Sup. Ct. 1982) (manufacturer of IUDs has a duty to 
warn only physicians as to dangers and side effects). 
98. See supra note 96. 
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ally impossible for a manufacturer to reach all of the consumers 
of its drug, or intrauterine device, thereby necessitating a warn-
ing through the doctor instead.99 
The Food and Drug Administration (FDA) apparently bal-
anced the necessity of a doctor's intervention against the manu-
facturer's difficulty in warning patients directly when it insti-
tuted its 1975 regulation that manufacturers provide patient 
inserts that include information on use-effectiveness, adverse re-
actions, directions for use, side effects, warnings, and special 
warnings about pregnancy with an IUD in place. loo This regula-
tion shows that the FDA at least, believes it is possible for man-
ufacturers to warn users by using the doctor as a conduit, and 
that there is value in giving technical information to consumers. 
It is questionable, however, whether such inserts are written 
with the consumer specifically in mind. It is also questionable 
whether merely requiring manufacturers to provide printed pa-
tient information to doctors exerts any control over whether the 
doctor provides the information to the patient before or after 
the IUD is inserted. 
A manufacturer of drugs has a duty to warn the medical 
profession within a reasonable time after it knew or should have 
known of the serious side effects of its drug. IOI A manufacturer 
has a duty to warn of all adverse reactions which it knows or has 
reason to know are inherent in the use of the drug. Compliance 
with FDA regulations regarding testing and warnings may not 
relieve the manufacturer of liability, as such regulations only es-
tablish minimum standards. lOS Liability may also be found when 
the facts disclose that the drug has not been properly prepared 
99. Fogo v. Cutter Laboratories, Inc., 68 Cal. App. 3d 744, 754-55, 137 Cal. Rptr. 
417,423 (1977). 
100. Package inserts accompanying IUDs must include warnings that "pelvic infec-
tion may occur with the IUD in place and at times result in development of tuboovarian 
. abcesses or general peritonitis." 21 C.F.R. § 801.427 (1975). This section also requires 
that pelvic infection be listed as an "adverse reaction" in the package insert for the 
doctor and in the package insert for the patient as well. The section requires that "label-
ing in sufficient quantities be available to patients who express interest in IUDs, shall 
accompany each IUD and be made available to the patient." [d. The patient brochure 
need not, however, include pelvic infection symptoms in the "side effects" section, but 
does include them in the "warnings" section. 
101. See supra note 93 and accompanying text. 
102. Stevens v. Parke, Davis & Co., 9 Cal. 3d 51, 65, 507 P.2d 653, 661, 107 Cal. 
Rptr. 45, 53 (1973). 
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and has been placed on the market without adequate and proper 
warnings. 103 
Even if the manufacturer fulfills its duty to warn ade-
quately, overpromotion of the drug through a vigorous sales pro-
gram may have the effect of persuading the doctor to disregard 
the warnings given. If overpromotion has such an effect, the 
manufacturer can be held liable even if its warnings alone were 
adequate.104 Overpromotion could have been "encouraged" by 
the pill panic1011 that swept the country in the early 1970's, by 
lack of FDA testing requirements at that time,106 and by the 
ability of the manufacturer to make a 1000% profit or more on a 
device that cost only about $.35 to produce. 107 
V. PROVING CAUSATION 
A plaintiff must show that the negligence (the breach of the 
duty owed) was a cause-in-fact and proximate cause of her in-
jury. In a strict liability case, plaintiff must show that the prod-
uct was defective and that the defect caused her injury. 
In a personal injury action, as in any other civil case, the 
plaintiff must prove that the wrongful act was more likely than 
not a substantial factor in causing the injury. One plaintiff's at-
torney in an IUD case has stated that defense attorneys often 
attempt to convince judges that the proper burden of proof is 
"reasonable medical certainty," or clear and convincing evidence 
that the defendant's product caused the injury, instead of the 
correct "more likely than not," preponderance test.108 Sentilles 
103. Toole v. Richardson Merrell, Inc., 251 Cal. App. 2d 689, 710-11, 60 Cal. Rptr. 
398, 413-14 (1967). See also Annot., 29 A.L.R. 3d 988 (1970). 
104. 9 Cal. 3d at 65, 507 P.2d at 661, 107 Cal. Rptr. at 53. 
105. Note, Criticism, supra note 21, at 272. 
106. The Food, Drug, and Cosmetics Act prohibits the marketing of any new drug 
until the manufacturer has met strict testing requirements to demonstrate the drug's 
safety. 21 U.S.C. § 355 (a)(1938 as amended). When IUDs were first put on the market 
the FDA classified them not as drugs, but as devices. Since 1968 the FDA has had the 
authority to classify IUDs as drugs and thus subject them to animal and controlled 
clinical studies. In spite of that authority, the FDA kept them classified as devices and so 
no pre-market controls· on manufacturing, testing or distribution could be imposed. 
Since 1976, however, the Medical Device Amendments Act, 21 U.S.C. § 360 (1976) 
has labeled IUDs as Class III devices requiring pre-market approval to provide reasona-
ble assurances of their safety and effectiveness. 
107. Note, Criticism, supra note 21, at 250. 
108. Interview with Dennis Conklin. plaintitrs personal injury attorney. San Fran-
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v. Inter-Caribbean Shipping Corp. lOB however, established that 
an expert's testimony does not have to establish causation by a 
"reasonable medical certainty" standard and that the jury is en-
titled to consider all possible medical conditions aggravating the 
plaintiff's injury or impairing her health. Grinnell v. Charles 
Pfizer & CO.110 made it clear that a plaintiff only has the burden 
of presenting evidence which affords a reasonable basis for the 
conclusion that it is more likely than not that the conduct of the 
defendant was a substantial factor in bringing about the injury 
suffered by plaintiff. 
In medical cases, there is always a problem of possible alter-
native causes in fact of the injury. This is certainly true in cases 
of PID, since gonorrhea, independently caused infection, previ-
ous PID, and an IUD can all be sources of the infection. Because 
of the prevalence of alternative causes of PID, "much of the evi-
dence will be circumstantial, based on reasonable probability, 
and will involve the opinion testimony of experts."lll 
Courts have been sensitive to problems faced by 
consumers or users of defective products in prov-
ing defect and proximate cause. . . the law recog-
nizes that in a product liability case proof of 
those elements by direct evidence is frequently 
impossible; a plaintiff may, therefore, satisfy his 
burden of proving defect and causation by cir-
cumstantial evidence. m 
It is very important that plaintiff have detailed medical 
records of her illness and in-depth medical analysis of its de-
tails,ll3 so that her expert witness can analyze this data in herl 
cisco, California (April 1982). 
109. 361 U.S. 107, 109 (1959). 
110. 274 Cal. App. 2d 424, 435, 79 Cal. Rptr. 369, 374. 
111. See Van Dyke, The Dalkon Shield: A "Primer" in IUD Liability, 6 W. ST. L. 
REV. 1 (1979). 
112. Diamond v. Caterpiller Tractor Co., 65 Cal. App. 3d 173, 183, 134 Cal. Rptr. 
895, 901 (1976). 
113. When an IUD is removed because of suspected PID, the device itself is often 
covered with bacteria. These IUDs are often disposed of immediately without perform-
ance of lab tests on the device. Interview with a Dalkon Shield plaintiff, San Francisco, 
California (March 1982). Even though such lab tests would only show the presence of 
infection, and wouldn't present the answer to the "chicken or the egg dilemma," that is, 
help to explain whether the infection arose independent of the device and caused the 
device to become infected, or whether the infection was caused by the device, such evi-
dence might be very useful to plaintiff. For example, if the string as well as the device 
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his testimony. As was discussed earlier,114 facts such as the di-
rection of the spreading of the infection, and which kind of bac-
teria caused plaintiff's infection, can be of vital importance in 
proving causation. Plaintiff's attorney must be well-versed in the 
current medical literature in order to examine effectively her/his 
experts and effectively cross-examine defendant's experts. 
If evidence of sexually transmitted bacteria was found at 
the time the IUD was removed, and especially if plaintiff is 
young and sexually active, defense attorneys may try to explore 
the plaintiff's sex life in an attempt to prove that the infection 
was related to her sexual activity rather than to her method of 
birth control. lUI Whether or not such questions can be explored 
at trial is up to the judge, as s/he determines what lines of ques-
tioning are relevant to the case. These questions, however, are 
also brought up in discovery in the form of interrogatories and 
deposition questions. Again, it is important that plaintiff's attor-
ney keep up with the latest medical studies in order to be better 
prepared to argue in favor of her/his refusal to answer such que-
ries. Again, the ultimate decision lies with the judge. It is most 
important for plaintiff's attorney to be thoroughly familiar with 
the medical literature in order to effectively refute damaging 
cross examination at trial. 
Plaintiff's attorney must gather the best statistics available 
on the probability and incidence of PID in women with IUDs, 
and the number of women with PID who have IUDs, and find an 
expert who is' comfortable using language establishing that the 
IUD "probably" rather than "possibly" caused the PID. 
The use of expert medical witnesses and studies which show 
statistical links between product and injury fly in the face of the 
legal requirements. Scientists oftentimes attempt to describe 
causation in terms of degrees instead of absolutes. They recog-
nize many different causes of any given event or result, and at-
were infected, this would tend to show that the device caused the infection. Or, if actino-
myces is found on the' device, and the plaintiff had no actinomyces in her history, a 
strong inference could be created that the IUD caused the infection. Obtaining lab re-
ports evidencing the presence of infection on the device, although not medically conclu-
sive, might be very convincing to a jury. 
114. Supra notes 33-36 and accompanying text. 
115. See supra note 34 and accompanying text. 
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tempt, through statistical methods, to isolate the degree to 
which different factors entered into the result. liS 
One physician, familiar with the problems of proving that 
tubal scarring was caused by an IUD, stated that doctors do not 
refuse to say that the infection was caused by the device because 
they fear being implicated in the suit, but rather because no 
doctor wants to say that anyone event was caused by any other 
event.11'7 There are too many variables involved in any medical 
result, and the key is isolating the one variable that was most 
likely to have had the greatest influence in bringing about the 
result. liS This is why statistical studies, in addition to detailed 
medical evidence about a particular case, are also very important 
in order to prove legal causation.1I9 
Courts in general are hostile to the idea of using statistical 
116. This technique is called multiple regression analysis. It is a device for making 
precise and quantitative estimates of the effects of different factors on the same variable. 
Multiple regression has frequently been used with the development of reliable statis-
tics and computers. "Some of the increasing use of multiple regression and related tech-
niques has occurred in connection with legal proceedings of various kinds, although law-
yers and judges have often tended to view such use with general (and occasionally 
healthy) distrust. "Fisher, Multiple Regression in Legal Proceedings, 80 COLUM. L. REV. 
702,702 (1980) [hereinafter cited as Multiple Regression). See also Finkelstein, The Ju-
dicial Reception of Multiple Regression Studies in Race and Sex Discrimination Cases, 
80 COLUM. L. REV. 737 (1980) [hereinafter cited as Judicial Reception). 
117. Interview with Jack Futeron, M.D., supra note 39. 
118. When multiple regression is used properly, it is an accurate and reliable 
method for determining the relationship between two or more variables and can be valu-
able in resolving factual disputes. Multiple Regression, supra note 116, at 736. 
119. The use of multiple regression models in a legal setting was first suggested in 
print in 1975 in Beyond the Prima Facie Case in Employment Discrimination Law: 
Statistical Proof and Rebuttal, 89 HARV. L. REV. 387 (1975). Since then its use has 
caught on very quickly in some areas of the law, mostly those involving discrimination. 
Judicial Reception, supra note 116, at 737. 
Use of statistical proof in law is a relatively new concept. Since Judicial Reception, 
supra note 116, was published, statistics have been used to prove causation more and 
more in other areas of law-particularly in toxic torts (harm to people from chemical 
dumping, hazardous wastes, exposure to hazardous substances on the job, etc.), where 
there is often a latency period between the exposure and the illness, and where there are 
often many possible alternative sources of the illness. In those kinds of cases statistical 
proof is more widely accepted, particularly in cases where plaintiff has virtually no direct 
evidence of causation and must rely entirely on circumstantial statistical proof. Lecture 
on causation in environmental cases by William Wick, EPA statl' attorney, and adjunct 
professor at Golden Gate University School of Law (March 1983). 
In light of all this, one could postulate that lack of the use of statistics to prove 
causation in products liability IUD cases is more a factor of the newness of the discipline 
than its inappropriateness to the field. 
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evidence to prove causation. no Statistical proof, however, has 
been accepted as valid evidence in cases of discrimination in em-
ployment, education, and housing.121 The primary advantage of 
statistical proof in these kinds of cases is its capacity to describe 
the general and long run characteristics and effects of a selection 
procedure.12l! That is, evidence of a small proportion of minori-
ties in a workforce, student body, or housing unit as compared 
to a higher proportion of such minorities in the surrounding la-
bor pool, student pool, or neighborhood, is valuable to indicate 
the possible discriminatory effects of a certain hiring, admission, 
or rental policy.12s Similar reasoning can be used to support the 
acceptance of statistical data in proving causation in IUD cases. 
Statistics can be valuable to show the characteristics and effects 
of the IUD on the reproductive organs. Statistics will also 
demonstrate that large numbers of women who use the same de-
vice suffer from the same disease, or that large numbers of 
women with a particular disease use the same method of birth 
control.124 
Under the disparate impact model of discrimination, uti-
lized under Title VII of the Civil Rights Act of 1964,1211 proof of 
a substantial adverse impact triggers a demand for justification, 
and if sufficient justification is not presented by defendant, s/he 
is held liable.128 In proving that defendant's actions were the 
cause of plaintiff's injuries in discrimination cases, the focus is 
not on the reasons behind defendant's actions, but rather on 
whether the disparate results were caused by a rule or procedure 
that defendant used, or whether those results were created by 
chance. 127 
A similar procedure might be considered for fulfilling re-
quirements of legal causation in IUD cases. Plaintiff's presenta-
120. Large and Miche, Prouing that the Strength of the British Nauy Depends on 
the Number of Old Maids in England: A Comparison of Scientific Proof With Legal 
Proof, 11 ENVTL. L. 555, 598-606 (1981) [hereinafter cited as Old Maids in England). 
121. [d. at 602. 
122. BALDUS & COLE, STATISTICAL PROOF OF DISCRIMINATION 4 (1980) [hereinafter 
cited as BALDUS & COLE). 
123. Old Maids in England, supra note 120, at 602. 
124. See notes 22-54 supra and accompanying text. 
125. 42 U.S.C. § 2000e-eI7 (1976). 
126. Griggs v. Duke Power Co., 401 U.S. 424 (1971). 
127. BALDUS & COLE, supra note 120, at 44-45. 
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tion of a disparately higher incidence of PID in women who Use 
IUDs would trigger a shifting of the burden of proof of causation 
to the defendant, who would then be required to prove that such 
impact was caused by chance and not by any characteristic of 
the product, the way it works, or by the manufacturer's lack of 
sufficient warnings and/or pre-market testing. 
The ordinary citizen who serves on a jury is presumed to, 
and urged to, use the same standards of probability in deliberat-
ing as s/he would use in everyday life.u8 Statistical models are 
useful to illustrate causal relationships from patterns in data, in 
order to give the jury a point of reference from which to work. 
"[S]tatistical findings may correct false impressions and provide 
assessments when there is no other basis for judgment."129 
Only one personal injury IUD case against a manufacturer 
has proceeded beyond preliminary motions, reached the appel-
late stage, and been reported.130 In Terhune v. A.H. Robins 
CO.131 plaintiff alleged that defendant's Dalkon Shield had perfo-
rated her uterus. The Washington Supreme Court held that 
plaintiff had failed to prove that the Shield was defective either 
in design or in manufacture, and that the principles of Comment 
K to the Second Restatement of Torts132 applied to the device. 
Comment K protects certain products from suit, particularly 
drugs, by deeming them "unavoidably unsafe" products whose 
utility outweighs their known dangers.1s3 Therefore, the manu-
facturers of these products are not liable for injuries caused by 
these dangers as long as such products are accompanied by 
proper warnings. The court in Terhune held that since Com-
ment K applied to IUDs, and plaintiff's doctor had been warned 
of its dangers, Robins would not be held liable.' The court never 
reached the causation issue. All other reported IUD cases were 
either tried on different grounds, such as medical malpractice, or 
foundered on the statute of limitations problem.134 
128. COHEN, THE PROBABLE AND THE PROVABI.E 49 (1977). 
129. FINKELSTEIN, QUANTITATIVE METHODS IN LAW 7 (1978). 
130. As of February 1983, the author was unable to find any reported cases involv-
ing the issue of causation in any IUD case. 
131. 577 P.2d 975 (Wash. Sup. Ct. 1978). 
132. RESTATEMENT (SECOND) OF TORTS § 402A(k) (1965). 
133. Id. 
134. See Simon v. A.H. Robins, 543 F. Supp. 502 (S.D.N.Y. 1981); In Re Northern 
District of California "Dalkon Shield IUD Products Liability Litigation, 526 F. Supp. 
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VI. CONCLUSION 
Despite the lack of guidelines as to what exactly will consti-
tute a winning case on the issue of causation, there is solid medi-
cal evidence establishing the IUD to be a cause of PID, which 
often leads to sterility. Recent medical journals have noted the· 
causal link between IUDs and PID and sterility in an effort to 
alert more doctors to the seriousness of the device's dangers. 1311 
In other areas of personal injury litigation, e.g., toxic inju-
ries and environmental injuries, it has been necessary to expand 
the established rules for proving causation in order to preserve 
the theories behind personal injury recovery and strict liability, 
and to provide relief to people injured by the negligence of large 
industries. 
[D]ifficulties in establishing proximate cause stem 
from the courts' refusal to accept scientific evi-
dence about carcinogenesis as legal evidence of 
causation. Cancer victims should not be precluded 
from recovering for their injuries solely because 
carcinogenesis is described by a statistical correla-
tion rather than by a cause-and-effect mechanism. 
Rather, the statistical correlation should be incor-
porated into the causation requirement so that 
the tort mechanism can effectively deter carcino-
gen production and prevent future cancer inci-
dence . . . The mere fact that the etiology of the 
injuries is complex should not shield . . . pro-
ducers from legal responsibility. "188 
The same should hold true for proving causation in IUD 
personal fnjury cases against manufacturers. Complex etiology 
887 (N.D. Cal. 1981); Nelson v. A.H. Robins, 515 F. Supp. 623 (N.D.N.Y. 1981); Rockwell 
v. Ortho Pharmaceutics Co., 510 F. Supp. 266 (N.D. Cal. 1981); Miller v. Mobile County 
Board of Health, 409 S. 2d 420 (Ala. Sup. Ct. 1982); Sciacca v. Polizzi, 403 S.2d 728 (La. 
Sup. Ct. 1981): Bayonne v. Hanford Ins. Co, 353 S.2d 1051 (La. Ct. App. 1977): McKee 
v. Moore, 648 P.2d 21 (Okla. Sup. Ct. 1982); Green v. Lilliewood, 249 S.E. 910 (S.C. Sup. 
Ct. 1978); Newberry v. Tarvin, 594 S.W. 204 (Tex. Ct. App. 1980); Doyle v. Planned 
Parenthood, 639 P.2d 240 (Wash. Ct. App. 1982). 
135. What Price Contraception?, S. MED. J., May 1981, at 523. 
136. Note, Tort Actions for Cancer: Deterrence, Compensation, and Environmental 
Carcinogenesis, 90 YALE L.J. 840, 854 (1981) (emphasis added). 
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requiring statistical and circumstantial evidence should not act 
to misplace the disasterous cost of industry produced sterility. 
Leslie Ellen Tick* 
• Third year student, Golden Gate University School of Law. 
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